Oncol Lett 9: [Related article:] 235-240, 2015; DOI:
10.3892/ol.2014.2663
Subsequently to the publication of the above paper,
an interested reader brought to the readers’ attention that some
statements and primer sequences in the paper had apparently been
presented incorrectly. The authors have considered the queries
raised by the reader, and acknowledge that there were errors
featured in the text of the paper and in the two Tables that are in
need of correction; therefore, they wish to publish a corrigendum
to rectify these issues.
First, the opening sentence of the “Tissue
slides” subsection of the Materials and methods section, in the
left-hand column on p. 236, incorrectly stated that the number of
normal brain paraffin-embedded samples was 14; the actual number of
normal specimens was 15, in agreement with what was written in
Table I. Secondly, in Table I on p. 237, the means of astrocytomas
was calculated incorrectly, and the actual mean should have been
written as 0.650 ± 0.138 (instead of 0.986±0.138); also, the actual
number of astrocytomas of pathological grade WHO I in Table I
should have been written as 22, not 23. Thirdly, in Table II on p.
238, the mean of astrocytomas was likewise presently incorrectly
owing to a calculation error: This should have been written as
0.694 ± 0.445 (instead of 0.677 ± 0.445).
Finally, the primer sequences for human WISP-2 cDNA
were reported incorrectly on p. 236; these should have been written
as follows: Forward primer, 5′-TTTCTGGCCTTGTCTCTTCC-3′ and reverse
primer, 5′-GCACAGGCGGCGCTGGGTCTC-3′.
Note that these errors do not affect the stated
conclusions of the paper. The authors are grateful to the Editor of
Oncology Letters for allowing them the opportunity to
publish this corrigendum, thank the reader of their article for
drawing these errors to their attention, and apologize to the
readership for any confusion caused.
